Hydrochloric Acid → HCID 131723149, 화합물
반응식
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([C:14]2[N:18]([CH2:19][CH3:20])[N:17]=[C:16]([CH2:21][CH3:22])[C:15]=2[CH3:23])[CH2:10][CH2:9]1)=O)(C)(C)C.[ClH:24]>CO>[ClH:24].[ClH:24].[CH2:19]([N:18]1[C:14]([CH:11]2[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]2)=[C:15]([CH3:23])[C:16]([CH2:21][CH3:22])=[N:17]1)[CH3:20]참가 물질
4
실험 절차
A solution of 1-(t-butoxycarbonyl)-4-(1,3-diethyl-4-methyl-(1H)-pyrazol-5-yl)piperidine (348 mg) (from Step E) in 2.5 N HCl in methanol was stirred at rt for 16 h. The solution was concentrated and the resulting solid was suspended in ethyl acetate, filtered and dried to afford 293 mg (92%) of the title compound.
후처리
- concentrationThe solution was concentrated
- filtrationfiltered
- customdried
출처 및 근거
- ORD 기록
- ord-59e19765ea0c45c0805cffacbbc01c4c
- 출처 데이터셋
- uspto-grants-2003_07
- 특허 번호
- US06593346B2
반응 노트
불러오는 중…